Specific Formulation of Xylo-Oligosaccharides and Isomalto-Oligosaccharides Alleviates Metabolic Disturbance and Intestinal Barrier Dysfunction Induced by High-Fat Diet
Journal of Agricultural and Food Chemistry · 2025
DOI: 10.1021/acs.jafc.5c07137 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Agricultural and Food Chemistry, 2025. Verfasst von Yiwen Li und 5 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Food Science and Resources, Jiangnan University, Wuxi 214122, China. Hauptthemen laut MEDLINE: Oligosaccharides, Intestinal Mucosa, Intestines, Xylans. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 77 Literaturangaben. Gefördert von: State Key Laboratory of Food Science and Resources, National Natural Science Foundation of China.
Abstract (Originalsprache)
This study investigated the effects of different xylo-oligosaccharides (XOS) and isomalto-oligosaccharides (IMO) ratios on systemic lipid homeostasis, gut microbiota, bile acid metabolism, and intestinal barrier integrity in high-fat diet mice. The findings demonstrated that the XOS:IMO (1:3) formulation significantly ameliorated dyslipidemia, inhibited ectopic fat deposition, and enhanced insulin sensitivity. Additionally, the formulation enriched beneficial gut microbiota, such as Coriobacteriaceae_UCG-002, while suppressing inflammation-associated pathogenic genera, including Enterorhabdus, Streptococcus, and Colidextribacter. Furthermore, the XOS:IMO (1:3) intervention significantly remodeled the bile acid metabolic profile, increasing bile acid concentrations that were negatively correlated with intestinal inflammatory biomarkers. Further analysis confirmed the preventive potential of this formulation, which alleviated colitis symptoms by reducing fecal calprotectin and inflammatory markers, while also improving intestinal barrier function by upregulating mucin and tight junction proteins. Collectively, the XOS:IMO (1:3) formulation demonstrated therapeutic potential for metabolic regulation and dietary inflammation prevention through gut microbiota-bile acid crosstalk modulation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Food Science and Resources, Jiangnan University, Wuxi 214122, China.
- School of Food Science and Technology, Jiangnan University, Wuxi 214122, China.
- Institute of Future Food Technology, JITRI, Yixing 214200, China.
ORCID-Profile: Xiaofeng Ban, Zhaofeng Li
Förderung
- State Key Laboratory of Food Science and Resources
- National Natural Science Foundation of China
Zitieren
APA
Li, Y., Kong, H., Li, C., Gu, Z., Ban, X., & Li, Z. (2025). Specific Formulation of Xylo-Oligosaccharides and Isomalto-Oligosaccharides Alleviates Metabolic Disturbance and Intestinal Barrier Dysfunction Induced by High-Fat Diet. Journal of Agricultural and Food Chemistry. https://doi.org/10.1021/acs.jafc.5c07137
Vancouver
Li Y, Kong H, Li C, Gu Z, Ban X, Li Z. Specific Formulation of Xylo-Oligosaccharides and Isomalto-Oligosaccharides Alleviates Metabolic Disturbance and Intestinal Barrier Dysfunction Induced by High-Fat Diet. Journal of Agricultural and Food Chemistry. 2025. doi:10.1021/acs.jafc.5c07137
BibTeX
@article{Li2025,
author = {Li, Yiwen and Kong, Haocun and Li, Caiming and Gu, Zhengbiao and Ban, Xiaofeng and Li, Zhaofeng},
title = {Specific Formulation of Xylo-Oligosaccharides and Isomalto-Oligosaccharides Alleviates Metabolic Disturbance and Intestinal Barrier Dysfunction Induced by High-Fat Diet},
journal = {Journal of Agricultural and Food Chemistry},
year = {2025},
doi = {10.1021/acs.jafc.5c07137}
}
EUVIMED